A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

NCT00448292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: PRX-00023
DRUG: Placebo for PRX-00023

Sponsor

Epix Pharmaceuticals, Inc.